** Pharmaceutical stocks slide 1.8% after U.S. President Donald Trump signals "major" tariff on pharma imports soon
** Nifty Pharma .NIPHARM index down 6.3% since April 4 when Trump first threatened the duties, ending the sector's brief reprieve
** According to Trump, the pharma duty will incentivise drug cos to move operations to the U.S.
** NIPHARM's all 20 constituents in the red; Gland Pharma GLAD.NS, Dr Reddy's Laboratories REDY.NS, Lupin LUPN.NS, IPCA Laboratories IPCA.NS lose between 2%-4.3%
** Sub-index extends YTD losses to 14.4% vs Nifty 50's .NSEI 5.1% fall
(Reporting by Aleef Jahan in Bengaluru)
((aleefjahan.cs@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。